Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 A comparison of Prostap SR and Prostap 3 M with regard to reduction in pain as a percentage

From: The effects of a 3-month depot preparation of leuprorelin acetate on pain symptoms, bone mineral density and hormone levels in women with endometriosis—preliminary data analysis


(Leuprorelin acetate, 3.75 mg [12])
Prostap SR
(Leuprorelin acetate, 11.25 mg)
Prostap 3M
Dysmenorrhoea 98.2% 88.5%
Dyspareunia 70.5% 73.1%
Non-menstrual pain 70.2% 55.1%